Anticoagulation
Patients in HHS have an increased risk of arterial and venous thromboembolism.
All patients should receive prophylactic low molecular weight heparin (LMWH) for the full duration of admission unless contraindicated.
Patients in HHS have an increased risk of arterial and venous thromboembolism.
All patients should receive prophylactic low molecular weight heparin (LMWH) for the full duration of admission unless contraindicated.